Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip De Keyser

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Rheumatology|July 7, 2012
Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniquesCarolien Bonroy, Vanessa Smith, Katleen Van Steendam, et al.
Annals of the Rheumatic Diseases|July 15, 2006
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitopeBert Vander Cruyssen, Ilse E A Hoffman, Isabelle Peene, et al.
Proteomics|April 23, 2005
Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometryKelly Tilleman, Katrien Van Beneden, Aline Dhondt, et al.
Arthritis and Rheumatism|March 29, 2002
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathyFilip Van Den Bosch, Elli Kruithof, Dominique Baeten, et al.
Current Rheumatology Reports|November 13, 2002
Gut inflammation and spondyloarthropathiesFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis developmentStijn Lambrecht, Vanessa Smith, Katelijne De Wilde, et al.
International Journal of Cardiology|April 9, 2016
Six-minute walk test in systemic sclerosis: A systematic review and meta-analysisEls Vandecasteele, Michel De Pauw, Filip De Keyser, et al.
Arthritis Research & Therapy|March 4, 2005
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathyDominique Baeten, Elli Kruithof, Leen De Rycke, et al.
Proteomics. Clinical Applications|December 8, 2010
In pursuit of B-cell synovial autoantigens in rheumatoid arthritis: Confirmation of citrullinated fibrinogen, detection of vimentin, and introducing carbonic anhydrase as a possible new synovial autoantigenKelly Tilleman, Ann Union, Tineke Cantaert, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre studyVanessa Smith, Carmen Pizzorni, Filip De Keyser, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Rheumatology|July 7, 2012
Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniquesCarolien Bonroy, Vanessa Smith, Katleen Van Steendam, et al.
Annals of the Rheumatic Diseases|July 15, 2006
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitopeBert Vander Cruyssen, Ilse E A Hoffman, Isabelle Peene, et al.
Proteomics|April 23, 2005
Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometryKelly Tilleman, Katrien Van Beneden, Aline Dhondt, et al.
Arthritis and Rheumatism|March 29, 2002
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathyFilip Van Den Bosch, Elli Kruithof, Dominique Baeten, et al.
Current Rheumatology Reports|November 13, 2002
Gut inflammation and spondyloarthropathiesFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis developmentStijn Lambrecht, Vanessa Smith, Katelijne De Wilde, et al.
International Journal of Cardiology|April 9, 2016
Six-minute walk test in systemic sclerosis: A systematic review and meta-analysisEls Vandecasteele, Michel De Pauw, Filip De Keyser, et al.
Arthritis Research & Therapy|March 4, 2005
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathyDominique Baeten, Elli Kruithof, Leen De Rycke, et al.
Proteomics. Clinical Applications|December 8, 2010
In pursuit of B-cell synovial autoantigens in rheumatoid arthritis: Confirmation of citrullinated fibrinogen, detection of vimentin, and introducing carbonic anhydrase as a possible new synovial autoantigenKelly Tilleman, Ann Union, Tineke Cantaert, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre studyVanessa Smith, Carmen Pizzorni, Filip De Keyser, et al.
Pageof 11